Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;91:371-372
doi: 10.1161/01.RES.0000033471.67751.85
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freedman, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freedman, J. E.
Related Collections
Right arrow Pathophysiology
Right arrow Cell biology/structural biology
Right arrow Cell signalling/signal transduction
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2002;91:371.)
© 2002 American Heart Association, Inc.


Editorials

Nitrated Lipids

Defining Their Bioactivity

Jane E. Freedman

From the Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Mass.

Correspondence to Jane E. Freedman, MD, Boston University School of Medicine, 715 Albany St, W507, Boston, MA 02118. E-mail freedmaj@bu.edu


Key Words: leukocytes • superoxide • nitric oxide • neutrophil


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Nitric oxide (NO) is an endogenously generated diffusible messenger that mediates a multitude of physiological and pathological processes. Normally, NO is produced in low concentrations and acts both as a messenger and cytoprotective factor via direct interactions with transition metals and other free radicals. However, in the setting of inflammation or shock, the substantial amounts of NO released may lead to the formation of cytotoxic species. When NO is transformed into a nitrating or nitrosating species it can readily react with many other factors potentially modulating their biological activity. These NO-dependent interactions are central in the regulation of many processes affecting vascular and atherothrombotic disease.

Previous studies have shown that NO reacts with both lipids and lipoproteins. The interaction of NO with oxidizing lipids can be either protective to the vasculature or enhance inflammatory-mediated vascular injury. In certain situations, low levels of NO generated by endothelial NO synthase (eNOS) can terminate lipid radical chain propagation reactions.1 Conversely, prooxidant reactions can occur after superoxide reacts with NO and leads to the formation of potent secondary oxidants, such as peroxynitrite and nitrogen dioxide, that can enhance inflammatory injury to vascular cells.2

Unsaturated lipids of membranes and lipoproteins can be critical targets of reactive oxygen and nitrogen species, suggesting potential relevance for nitrogen-containing lipid products. When NO is transformed into a nitrating and nitrosating species, it has been shown to react with unsaturated lipids.3,4 Recently, such nitrated lipids have been demonstrated to be formed in vivo.5 The oxidation product of NO, NO2, . . . [Full Text of this Article]